This study followed seven adult patients with both PSC and ulcerative colitis. All patients were treated for at least six months with oral vancomycin doses between 250 mg – 1,500 mg per day. All patients achieved clinical remission with their ulcerative colitis. Labs that decreased included: fecal calprotectin, C-reactive protein, the Mayo score, alkaline phosphatase, […]
Vancomycin for PSC Q&A with Dr. Davies: Presented by the Children’s PSC Foundation
In 2011, Dr. Yinka Davies, a pediatric gastroenterologist, held a teleconference call with the parents of children with PSC patients. The conversation was recorded into a written Q&A format. Topics cover: • Vancomycin safety, side effects, and vancomycin-resistant bacteria • The use of probiotics when taking vancomycin • The effect of vancomycin on other autoimmune […]